aInserm U1107 NEURO-DOL, Pharmacologie fondamentale et clinique de la douleur, Université Clermont Auvergne, Clermont-Ferrand, France
bUnité d'imagerie par résonance Magnétique et spectroscopie CEA/DRF/I2BM/NeuroSpin, Gif-Sur-Yvette, France
cLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal
dICVS/3B's-PT Government Associate Laboratory, Guimarães, Braga, Portugal
eINRA, Centre Auvergne-Rhône Alpes, platforme Agroresonance, Saint Genès Champanelle, France
*Corresponding author. Address: UMR Inserm/UCA 1107, NeuroDol Laboratoire de Pharmacologie Fondamentale et Clinique de la Douleur, BP 10448, F-63000 Clermont-Ferrand, France. Tel.: 0033 473 178 231. E-mail address: [email protected] (D.A. Barrière).
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.painjournalonline.com).